Last reviewed · How we verify

NCT03774511: [PTREC]

Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial

Completed NA Last updated 26 June 2020
What this trial tests

NA trial testing High-Intensity Interval Exercise & Moderate Intensity Interval Exercise in Diabetes in 48 participants. Completed in 10 December 2018.

Timeline
9 July 2017
Primary endpoint
10 August 2018
10 December 2018

Quick facts

Lead sponsorAhlia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment48
Start date9 July 2017
Primary completion10 August 2018
Estimated completion10 December 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ahlia University

Who can join

Adults 40 to 60, any sex, with Diabetes or Nonalcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

background: Obesity, diabetes mellitus type II and fatty liver disease combining with low levels of physical activity are prominent health risks for mortality and morbidity. More than 1/3 of the current population is suffering from obesity with a significant proportion to medical complications which can negatively influence their quality of life. These complications comprise alterations of the metabolism of glucose and fat, insulin resistance and diabetes mellitus. Objectives The purpose of this study was to compare between high intensity interval exercise and moderate intensity continuous on diabetic obese patients with NAFLD. Methods: forty-seven diabetic obese individuals with NAFLD were enrolled in this study. The individuals were randomly divided into 16 in HII group, 15 in MIC group, and 16 in the controls. HII group received HII exercise, MIC group received 8-week MIC exercise while the control group did not receive any exercise intervention. IHTG and visceral lipids were assessed pre- and post-intervention.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial.
    Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, et al · · 2020 · cited 71× · PMID 32150108 · DOI 10.1097/md.0000000000019471
  2. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
    Buzzetti E, Linden A, Best LM, Madden AM, et al · · 2021 · cited 28× · PMID 34114650 · DOI 10.1002/14651858.cd013156.pub2
  3. Retracted: Effect of Moderate-Intensity Aerobic Exercise on Hepatic Fat Content and Visceral Lipids in Hepatic Patients with Diabesity: A Single-Blinded Randomised Controlled Trial.
    And Alternative Medicine EC. · · 2023 · PMID 37854275 · DOI 10.1155/2023/9829387
  4. Erratum.
    · 2020 · PMID 32925802 · DOI 10.1097/md.0000000000022388

Verify or expand the search:

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other Ahlia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03774511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing